MC
UTMD icon

Menta Capital’s Utah Medical Products UTMD Stock Holding History

Menta Capital’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,553
Closed -$346K – 931
2017
Q1 		$346K Hold
5,553
– – 0.03% 658
2016
Q4 		$404K Buy
5,553
+157
+3% +$10.2K 0.03% 676
2016
Q3 		$323K Buy
5,396
+809
+18% +$51.5K 0.03% 666
2016
Q2 		$289K Buy
+4,587
New +$296K 0.04% 693

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Menta Capital's UTMD Position: Q2 2017 in Review

Menta Capital sold out of Utah Medical Products (UTMD) in Q2 2017, closing a stake of 5,553 shares — an estimated $346K sold.

Menta Capital first reported a position in UTMD in Q2 2016 and held it in 4 quarters. The position peaked at $404K in Q4 2016. 76 funds tracked by Wall St. Rank hold UTMD as of Q2 2017.

  • Menta Capital reported no remaining Utah Medical Products position as of Q2 2017 after selling out during the quarter.
  • Menta Capital sold 5,553 Utah Medical Products shares in Q2 2017, an estimated $346K.
  • Menta Capital first reported a position in Utah Medical Products in Q2 2016 and held it in 4 quarters.
  • Menta Capital's Utah Medical Products position peaked at $404K in Q4 2016.
  • 76 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2017.

Based on Menta Capital's 13F filing for Q2 2017, filed 11 Aug 2017.